Bendamustine hydrochloride 100 MG Injection — RxCUI 1805001
RxNorm drug concept · Semantic clinical drug
RxCUI 1805001
Semantic clinical drug · SCD
● Current RxNorm concept 9 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1805001
Official nameBendamustine hydrochloride 100 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbendamustine HCl 100 MG Injection
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)208 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bendamustine Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Bendamustine is a chemotherapy drug used to treat two types of blood cancer in adults: chronic lymphocytic leukemia (CLL) and a slow-growing type called indolent B-cell non-Hodgkin...
- No, bendamustine is always given as an IV infusion at a clinic, infusion center, or hospital — never at home. You'll receive it through a vein on two days in a row, followed by a r...
- How will I receive this treatment — do I take it at home?
- Nausea, fatigue, and fever are among the most common things people notice. Low blood counts are also very common — this includes low white blood cells, red blood cells, and platele...
🕸️ Concept Web — How Bendamustine hydrochloride 100 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Bendamustine hydrochloride 100 MG Injection
RxCUI 1805001 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Bendamustine
134547IN -
Bendamustine hydrochloride
1114693PIN
-
Bendamustine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Treanda
741098BN
-
Treanda
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bendamustine Injection
1805000SCDF -
Bendamustine hydrochloride Injection
2646014SCDFP -
Bendamustine Injectable Product
1160009SCDG -
Bendamustine hydrochloride Injectable Product
2662801SCDGP -
Bendamustine Injection [Treanda]
1805003SBDF -
Bendamustine hydrochloride Injection [Treanda]
2655434SBDFP -
Treanda Injectable Product
1179668SBDG -
Injection
1649574DF - +1 more in this family
-
Bendamustine Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bendamustine hydrochloride 100 MG
1804999SCDC -
Bendamustine hydrochloride 100 MG Injection [Treanda]
1805004SBD -
Bendamustine hydrochloride 100 MG [Treanda]
1805002SBDC
-
Bendamustine hydrochloride 100 MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bendamustine hydrochloride 100 MG
SCDC · 1804999 -
Bendamustine Injection
SCDF · 1805000 -
Bendamustine hydrochloride Injection
SCDFP · 2646014 -
Bendamustine Injectable Product
SCDG · 1160009 -
Bendamustine hydrochloride Injectable Product
SCDGP · 2662801
Brand-Name Concepts
-
Bendamustine hydrochloride 100 MG Injection [Treanda]
SBD · 1805004 -
Bendamustine hydrochloride 100 MG [Treanda]
SBDC · 1805002 -
Bendamustine Injection [Treanda]
SBDF · 1805003 -
Bendamustine hydrochloride Injection [Treanda]
SBDFP · 2655434 -
Treanda Injectable Product
SBDG · 1179668 -
Treanda
BN · 741098
📦 FDA Products & Package NDCs
9 products · 9 package NDCs
9 package NDCs map to RxCUI 1805001 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 16729-0250-03 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16729-250-03) / 5 mL in 1... | bendamustine hydrochloride | Accord Healthcare, Inc. | 2022-12-07 |
| 16729-0251-05 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16729-251-05) / 20 mL in 1... | bendamustine hydrochloride | Accord Healthcare, Inc. | 2022-12-07 |
| 55150-0391-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-391-01) / 5 mL in 1... | BENDAMUSTINE HYDROCHLORIDE | Eugia US LLC | 2023-06-05 |
| 55150-0392-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-392-01) / 20 mL in 1... | BENDAMUSTINE HYDROCHLORIDE | Eugia US LLC | 2023-06-05 |
| 63459-0390-08 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63459-390-08) / 5 mL in 1... | TREANDA | Cephalon, LLC | 2010-01-05 |
| 63459-0391-20 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63459-391-20) / 20 mL in 1... | TREANDA | Cephalon, LLC | 2008-03-31 |
| 68001-0572-41 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-572-41) / 20 mL in 1... | bendamustine hydrochloride | BluePoint Laboratories | 2023-10-15 |
| 71288-0102-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-102-10) / 5 mL in 1... | Bendamustine | Meitheal Pharmaceuticals Inc. | 2023-06-05 |
| 71288-0103-20 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-103-20) / 20 mL in 1... | Bendamustine | Meitheal Pharmaceuticals Inc. | 2023-06-05 |
Observed labelers:
Accord Healthcare, Inc. (2) ·
Cephalon, LLC (2) ·
Eugia US LLC (2) ·
Meitheal Pharmaceuticals Inc. (2) ·
BluePoint Laboratories (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9033 | Inj, bendamustine hcl, 1mg | 9 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.